Netherlands

GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together.

We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance.

We prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We will focus on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

GSK employee walking to work while holding a coffee

We have been operating in the Netherlands since 1921 and we have a little over 200 employees. Our office is in Amersfoort. In addition, a Centre of Excellence for GSK R&D has been established in Amsterdam, where the main activity is focused on collecting and processing clinical data.

We are convinced that collaborations lead to great innovations. GSK Netherlands is an active member of the Association Innovative Medicines (VIG) and HollandBio.

As a global healthcare company, we set ambitious environmental sustainability goals. Following these ambitions, we have signed the Green Deal Sustainable Care in the Netherlands. We believe that everyone can make a positive contribution in making the world a better place. We work on it daily with key partners and suppliers in the entire chain. In addition, as a modern employer, we believe it is important that there are social sustainability programs around health, well-being, development, inclusivity, and diversity.

Contact details

GlaxoSmithKline BV
Van Asch van Wijckstraat 55H
Amersfoort
3811 LP
Tel: 033-208 1100


Press enquiries: 033-2081100
Outside office hours: +31 (0) 6 13 51 11 88 / +31 (0) 6 53 84 58 37

Back to top

Health professionals in the Netherlands can obtain information about products and areas of therapy related to GSK by visiting GSKPro.

Back to top

Disclaimer 

The content on this web page is written by our Dutch local operating company for their home audience, not the UK, and may not align with UK regulations. Following links on this page, will take you to content on our global site, which follows UK regulations; or third party content.